{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,12]],"date-time":"2026-09-12T22:59:38Z","timestamp":1789253978691,"version":"build-2803163510"},"reference-count":33,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T00:00:00Z","timestamp":1651795200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100021356","name":"Fondation du Grand d\u00e9fi Pierre Lavoie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021356","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Vitamin D-dependant rickets type 1A (VDDR1A) is a rare autosomal recessive disorder caused by pathogenic variants in the <jats:italic>CYP27B1<\/jats:italic> gene. This gene is essential for vitamin D activation. Although VDDR1A is a rare condition worldwide, its prevalence is high in the Saguenay-Lac-Saint-Jean (SLSJ) region due to a founder effect. Daily intake of calcitriol before the onset of clinical manifestations can prevent them in affected children.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>A genetic screening test was developed and validated for the <jats:italic>CYP27B1<\/jats:italic> gene c.262del pathogenic variant. Newborn screening was implemented in the SLSJ region for this variant, and the feasibility and acceptability were assessed. Sixteen medical records of children affected with VDDR1A were reviewed to document the consequences of the disease at diagnosis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>A total of 2000 newborns were tested for VDDR1A. Most families (96.5%) accepted the genetic test. We found a carrier rate of 1\/29 for the c.262delG variant in our cohort, which is suggestive of a founder effect. We identified one child affected with VDDR1A and treatment was initiated before the onset of clinical manifestations. On average, children with VDDR1A were diagnosed at 13.8 \u00b1 5 months of age, they had a significant failure to thrive at diagnosis, among other harmful health consequences.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Our study showed that in our population, the newborn genetic screening program is safe and feasible, it has high acceptability, and it is efficient to identify affected children. VDDR1A health consequences can be prevented by early initiation of treatment. Therefore, screening programs should be available for populations where it is deemed as beneficial from a public health perspective.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fendo.2022.887371","type":"journal-article","created":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:37:08Z","timestamp":1651819028000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":11,"title":["Benefits of Newborn Screening for Vitamin D-Dependant Rickets Type 1A in a Founder Population"],"prefix":"10.3389","volume":"13","author":[{"given":"Carol-Ann","family":"Fortin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lysanne","family":"Girard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chlo\u00e9","family":"Bonenfant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josianne","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Cruz-Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Eve","family":"Blackburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Desmeules","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bouchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,5,6]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1359\/jbmr.1997.12.10.1552","article-title":"The 25-Hydroxyvitamin D 1-Alpha-Hydroxylase Gene Maps to the Pseudovitamin D-Deficiency Rickets (PDDR) Disease Locus","volume":"12","author":"St-Arnaud","year":"1997","journal-title":"J Bone Miner Res"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1210\/mend.11.13.0035","article-title":"Cloning of Human 25-Hydroxyvitamin D-1 Alpha-Hydroxylase and Mutations Causing Vitamin D-Dependent Rickets Type 1","volume":"11","author":"Fu","year":"1997","journal-title":"Mol Endocrinol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D Deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21186573","article-title":"An Update on Vitamin D Metabolism","volume":"21","author":"Saponaro","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1086\/302156","article-title":"Genetics of Vitamin D 1alpha-Hydroxylase Deficiency in 17 Families","volume":"63","author":"Wang","year":"1998","journal-title":"Am J Hum Genet"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199803053381004","article-title":"Inactivating Mutations in the 25-Hydroxyvitamin D3 1alpha-Hydroxylase Gene in Patients With Pseudovitamin D-Deficiency Rickets","volume":"338","author":"Kitanaka","year":"1998","journal-title":"N Engl J Med"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1210\/jcem.84.11.6131","article-title":"No Enzyme Activity of 25-Hydroxyvitamin D3 1alpha-Hydroxylase Gene Product in Pseudovitamin D Deficiency Rickets, Including That With Mild Clinical Manifestation","volume":"84","author":"Kitanaka","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1002\/humu.10212","article-title":"Human Gene Mutation Database (HGMD): 2003 Update","volume":"21","author":"Stenson","year":"2003","journal-title":"Hum Mutat"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1515\/jpem-2021-0403","article-title":"Genotype and Phenotypic Spectrum of Vitamin D Dependent Rickets Type 1A: Our Experience and Systematic Review","volume":"34","author":"Dodamani","year":"2021","journal-title":"J Pediatr Endocrinol Metab"},{"key":"B10","doi-asserted-by":"publisher","first-page":"88","DOI":"10.4274\/jcrpe.2017.S008","article-title":"Genetic Causes of Rickets","volume":"9","author":"Acar","year":"2017","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3389\/fped.2020.00315","article-title":"Diagnosis and Management of Vitamin D Dependent Rickets","volume":"8","author":"Levine","year":"2020","journal-title":"Front Pediatr"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM197811022991803","article-title":"Serum 1,25-Dihydroxyvitamin D Levels in Normal Subjects and in Patients With Hereditary Rickets or Bone Disease","volume":"299","author":"Scriver","year":"1978","journal-title":"N Engl J Med"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2010-1340","article-title":"Short- and Long-Term Outcome of Patients With Pseudo-Vitamin D Deficiency Rickets Treated With Calcitriol","volume":"96","author":"Edouard","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"B14","article-title":"Vitamin D Hydroxylation\u2013Deficient Rickets, Type 1a: CYP27B1 Mutations","volume-title":"Vitamin D, Volume II: Health, Disease and Therapeutics","author":"Glorieux F","year":"2018"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1210\/er.2013-1009","article-title":"The Rachitic Tooth","volume":"35","author":"Foster","year":"2014","journal-title":"Endocr Rev"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1136\/jmedgenet-2021-107809","article-title":"Genetic Burden Linked to Founder Effects in Saguenay-Lac-Saint-Jean Illustrates the Importance of Genetic Screening Test Availability","volume":"58","author":"Bchetnia","year":"2021","journal-title":"J Med Genet"},{"key":"B17","article-title":"Mouvements Migratoires Et Familles: Le Peuplement Du Saguenay Avant 1911","volume":"42","author":"Gauvreau","year":"1988","journal-title":"haf"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1159\/000153992","article-title":"Hereditary Disorders in Saguenay-Lac-St-Jean (Quebec, Canada)","volume":"41","author":"De Braekeleer","year":"1991","journal-title":"Hum Hered"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-1809.1991.tb00855.x","article-title":"Population Genetics of Vitamin D-Dependent Rickets in Northeastern Quebec","volume":"55","author":"De Braekeleer","year":"1991","journal-title":"Ann Hum Genet"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1046\/j.1523-1755.1998.00133.x","article-title":"Two Novel 1alpha-Hydroxylase Mutations in French-Canadians With Vitamin D Dependency Rickets Type I1","volume":"54","author":"Yoshida","year":"1998","journal-title":"Kidney Int"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/nu12082202","article-title":"Failure to Thrive in the Outpatient Clinic: A New Insight","volume":"12","author":"Lezo","year":"2020","journal-title":"Nutrients"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000022508","article-title":"Long-Term Dental Intervention and Laboratory Examination in a Patient With Vitamin D-Dependent Rickets Type I: A Case Report","volume":"99","author":"Liu","year":"2020","journal-title":"Med (Baltimore)"},{"key":"B23","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4274\/jcrpe.galenos.2018.2018.0121","article-title":"Genetic and Clinical Characteristics of Patients With Vitamin D Dependent Rickets Type 1a","volume":"11","author":"Dursun","year":"2019","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"B24","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1159\/000446774","article-title":"A Case of Vitamin-D-Dependent Rickets Type 1A With Normal 1,25-Dihydroxyvitamin D Caused by Two Novel Mutations of the CYP27B1 Gene","volume":"87","author":"Giannakopoulos","year":"2017","journal-title":"Horm Res Paediatr"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s00198-018-4607-5","article-title":"Mutation Update and Long-Term Outcome After Treatment With Active Vitamin D3 in Chinese Patients With Pseudovitamin D-Deficiency Rickets (PDDR)","volume":"30","author":"Chi","year":"2019","journal-title":"Osteoporos Int"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1159\/000444483","article-title":"Genotype and Phenotype Characteristics in 22 Patients With Vitamin D-Dependent Rickets Type I","volume":"85","author":"Tahir","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0131376","article-title":"Novel CYP27B1 Gene Mutations in Patients With Vitamin D-Dependent Rickets Type 1a","volume":"10","author":"Demir","year":"2015","journal-title":"PloS One"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2265.2012.04394.x","article-title":"Clinical and Genetic Analysis of Patients With Vitamin D-Dependent Rickets Type 1A","volume":"77","author":"Durmaz","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1007\/s00223-020-00784-2","article-title":"Does Genotype-Phenotype Correlation Exist in Vitamin D-Dependent Rickets Type IA: Report of 13 New Cases and Review of the Literature","volume":"108","author":"Kaygusuz","year":"2021","journal-title":"Calcif Tissue Int"},{"key":"B30","unstructured":"WilsonJMG\n            JungnerG\n          Principles and Practice of Screening for Disease \/ J. M. G. Wilson, G. Jungner1968"},{"key":"B31","article-title":"Screening: When Is It Appropriate and How Can We Get It Right","author":"Sagan","year":"2020"},{"key":"B32","volume-title":"Criteria for Appraising the Viability, Effectiveness and Appropriateness of a Screening Programme","year":"2015"},{"key":"B33","volume-title":"Pertinence D\u2019\u00e9largir Le Programme De D\u00e9pistage N\u00e9onatal Sanguin Au Qu\u00e9bec","author":"C\u00f4t\u00e9","year":"2013"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.887371\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,5,6]],"date-time":"2022-05-06T06:37:12Z","timestamp":1651819032000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2022.887371\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,5,6]]},"references-count":33,"alternative-id":["10.3389\/fendo.2022.887371"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2022.887371","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,5,6]]},"article-number":"887371"}}